NKGen Biotech Inc. Common...

AI Score

XX

Unlock

0.18
0.00 (0.00%)
At close: Mar 31, 2025, 3:29 PM
0.18
0.00%
After-hours: Mar 31, 2025, 03:29 PM EDT

NKGen Biotech Common Stock Balance Sheet Statement

Year FY23 FY22 FY21
Cash & Equivalents 26K 117K 351K
Short-Term Investments n/a n/a n/a
Long-Term Investments n/a 173.49M 171.66M
Other Long-Term Assets n/a -173.49M -171.66M
Receivables 26K 96K 67K
Inventory n/a 133K 172K
Other Current Assets 1.88M 137K 194K
Total Current Assets 1.93M 350K 612K
Property-Plant & Equipment 14.46M 15.88M 17.37M
Goodwill & Intangibles 92K 97K 89K
Total Long-Term Assets 14.55M 15.98M 17.46M
Total Assets 16.48M 16.33M 18.07M
Account Payables 11.04M 975K 1.71M
Deferred Revenue n/a 1.65M 2.35M
Short-Term Debt 9.99M 12.03M 51.61M
Other Current Liabilities 18.42M 1.55M 2.42M
Total Current Liabilities 39.45M 14.74M 55.74M
Long-Term Debt 9.93M n/a 360K
Other Long-Term Liabilities 25.76M n/a n/a
Total Long-Term Liabilities 35.72M 26K 379K
Total Liabilities 75.17M 14.77M 56.12M
Total Debt 19.92M 12.03M 51.97M
Common Stock 2K 33K 14K
Retained Earnings -162.13M -79.18M -52.42M
Comprehensive Income n/a n/a n/a
Shareholders Equity -58.69M 1.56M -38.05M
Total Investments 18.29M 173.49M 171.66M